Sale!

Prenatal Delta Beta- Thalassaemia Mutation Screening Test Cost

Original price was: 2,000 د.إ.Current price is: 1,500 د.إ.

-25%

The Prenatal Delta Beta-Thalassaemia Mutation Screening Test is a critical diagnostic tool offered by DNA Labs UAE, aimed at expecting parents who wish to assess the risk of their unborn child inheriting Delta Beta-Thalassemia. This condition is a form of thalassemia that affects the production of hemoglobin, leading to anemia and other health complications. The screening test specifically looks for mutations in the genes responsible for hemoglobin production, helping to predict the likelihood of the fetus developing this blood disorder.

Performed during pregnancy, this test provides vital information that can assist in planning for any necessary medical interventions or preparations. It is especially recommended for couples with a family history of thalassemias or those belonging to ethnic backgrounds with a higher prevalence of these conditions.

The cost of the Prenatal Delta Beta-Thalassaemia Mutation Screening Test at DNA Labs UAE is set at 1500 AED. This investment covers the sophisticated genetic analysis required to detect the presence of the mutations associated with the condition. Conducting the test in a reputable laboratory like DNA Labs UAE ensures accuracy and reliability of the results, offering peace of mind and essential health insights for expecting parents.

Description

Prenatal Delta Beta- Thalassaemia Mutation Screening Test

Test Name: Prenatal Delta Beta- Thalassaemia mutation screening Test

Components: Sterile container/ Sterile Normal Saline Container/ EDTA Vacutainer

Price: 1500.0 AED

Sample Condition: Amniotic fluid/ Chorionic villi/ Peripheral blood

Report Delivery: 5-6 days

Method: End Point PCR

Test Type: Genetics

Doctor: General Physician

Test Department:

Pre Test Information: Prenatal Delta Beta- Thalassaemia mutation screening can be done with a Doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details: Prenatal Delta Beta-Thalassaemia mutation screening is a genetic test performed during pregnancy to detect specific mutations in the Delta and Beta-globin genes associated with Thalassaemia. Thalassaemia is a group of inherited blood disorders characterized by abnormal production of hemoglobin, the protein responsible for carrying oxygen in the blood. The screening is typically recommended for couples who are carriers of Thalassaemia or have a family history of the condition. It helps to determine the risk of the fetus inheriting the disease and allows parents to make informed decisions regarding the pregnancy. During the screening, a sample of the fetus’s DNA is collected, usually through chorionic villus sampling (CVS) or amniocentesis. The DNA is then analyzed in a laboratory to identify any specific mutations in the Delta and Beta-globin genes. If the screening identifies a mutation, further testing may be recommended to confirm the diagnosis and assess the severity of the condition. This information can help healthcare providers and parents develop a management plan for the affected child, which may include regular blood transfusions, iron chelation therapy, and other supportive treatments. Prenatal Delta Beta-Thalassaemia mutation screening is an important tool in prenatal care for couples at risk of having a child with Thalassaemia. It allows for early detection and appropriate management of the condition, improving the outcomes for affected individuals and their families.

Test Name	Prenatal Delta Beta- Thalassaemia mutation screening Test
Components	Sterile container/ Sterile Normal Saline Container/ EDTA Vacutainer
Price	1500.0 AED
Sample Condition	Amniotic fluid\/ Chorionic villi\/ Peripheral blood
Report Delivery	5-6 days
Method	End Point PCR
Test type	Genetics
Doctor	General Physician
Test Department:
Pre Test Information	Prenatal Delta Beta- Thalassaemia mutation screening can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details	Prenatal Delta Beta-Thalassaemia mutation screening is a genetic test performed during pregnancy to detect specific mutations in the Delta and Beta-globin genes associated with Thalassaemia. Thalassaemia is a group of inherited blood disorders characterized by abnormal production of hemoglobin, the protein responsible for carrying oxygen in the blood. The screening is typically recommended for couples who are carriers of Thalassaemia or have a family history of the condition. It helps to determine the risk of the fetus inheriting the disease and allows parents to make informed decisions regarding the pregnancy. During the screening, a sample of the fetus’s DNA is collected, usually through chorionic villus sampling (CVS) or amniocentesis. The DNA is then analyzed in a laboratory to identify any specific mutations in the Delta and Beta-globin genes. If the screening identifies a mutation, further testing may be recommended to confirm the diagnosis and assess the severity of the condition. This information can help healthcare providers and parents develop a management plan for the affected child, which may include regular blood transfusions, iron chelation therapy, and other supportive treatments. Prenatal Delta Beta-Thalassaemia mutation screening is an important tool in prenatal care for couples at risk of having a child with Thalassaemia. It allows for early detection and appropriate management of the condition, improving the outcomes for affected individuals and their families.